Biopharma deal intelligence

An intuitive biopharma deals database.

Access highly curated deal information, with clean data and clear context for your research.

597 curated transactions2018–2026 YTD dataData reviewed 2026-09-30Coverage & methodology ↗

Find your reference set

Start with one or two criteria. Add detail to refine your search.

Therapeutic area

Indication

Modality

Stage at signing

Advanced settings

Licensor country

Licensee country

Minimum relevance

Comps per page

Matching weights

Relative weights, 0–100. Zero disables a criterion. At least 50% weighted data coverage is required; all qualifying transactions feed the benchmarks regardless of page.

Therapeutic area

Development stage

Modality

Indication

Licensor country

Licensee country

TA, modality and stage use standardized categories. Transactions may carry multiple TA or modality labels; original source values remain in the results. Indication uses phrase matching.

Clear search

01 / COMPS

Find the relevant precedents

See what matches your asset and where the evidence is incomplete.

02 / DEAL TERMS

Put disclosed terms in context

Review the range of economics alongside the sample behind each figure.

03 / HISTORICAL PARTNERS

Build an informed shortlist

Explore past licensing activity and select companies for further research.